Instead, STB-HO treatment decreased the expression of HLA class I molecule, a well-known inhibitory ligand for NK cell function, on the surface of MCF-7 cells, indicating that cancer cells exposed to STB-HO might be more susceptible to NK cell cytotoxicity. This evidence concerns the gene HMOX1 and cancer.